1
|
Harrison JD, Oatway WB, Brown IK, Hopewell JW. Health risks from radioactive particles on Cumbrian beaches near the Sellafield nuclear site. J Radiol Prot 2023; 43:031504. [PMID: 37339608 DOI: 10.1088/1361-6498/acdfd6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Accepted: 06/20/2023] [Indexed: 06/22/2023]
Abstract
A monitoring programme, in place since 2006, continues to recover radioactive particles (<2 mm diameter) and larger objects from the beaches of West Cumbria. The potential risks to members of the public using the beaches are mainly related to prolonged skin contact with or the inadvertent ingestion of small particles. Most particles are classified as either 'beta-rich' or 'alpha-rich' and are detected as a result of their caesium-137 or americium-241 content. Beta-rich particles generally also contain strontium-90, with90Sr:137Cs ratios of up to about 1:1, but typically <0.1:1. Alpha-rich particles contain plutonium isotopes, with Pu:241Amαratios usually around 0.5-0.6:1. 'Beta-rich' particles have the greatest potential to cause localised skin damage if held in stationary contact with the skin for prolonged periods. However, it is concluded that only particles of >106Bq of137Cs, with high90Sr:137Cs ratios, would pose a significant risk of causing acute skin ulceration. No particles of this level of activity have been found. Inadvertent ingestion of a particle will result in the absorption to blood of a small proportion of the radionuclide content of the particle. The subsequent retention of radionuclides in body organs and tissues presents a potential risk of the development of cancer. For 'beta-rich' particles with typical activities (mean 2 × 104Bq137Cs, Sr:Cs ratio of 0.1:1), the estimated committed effective doses are about 30µSv for adults and about 40µSv for 1 year old infants, with lower values for 'alpha-rich' particles of typical activities. The corresponding estimates of lifetime cancer incidence following ingestion for both particle types are of the order of 10-6for adults and up to 10-5for infants. These estimates are subject to substantial uncertainties but provide an indication of the low risks to members of the public.
Collapse
Affiliation(s)
- John D Harrison
- Oxford Brookes University, Faculty of Health and Life Sciences, Oxford OX3 0BP, United Kingdom
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Directorate, Chilton, Didcot, Oxon OX11 0RQ, United Kingdom
| | - Wayne B Oatway
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Directorate, Chilton, Didcot, Oxon OX11 0RQ, United Kingdom
| | - Iain K Brown
- UK Health Security Agency, Radiation, Chemical and Environmental Hazards Directorate, Chilton, Didcot, Oxon OX11 0RQ, United Kingdom
| | - John W Hopewell
- Green Temple College, University of Oxford, Oxford OX2 6HG, United Kingdom
- Department of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom
| |
Collapse
|
2
|
Poudel D, Dumit S, Klumpp JA. Effectiveness of Surgical Excision Following Plutonium-contaminated Wounds: Inferences from Historical Cases. Health Phys 2023; 124:462-474. [PMID: 36880975 DOI: 10.1097/hp.0000000000001686] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
ABSTRACT As with any medical treatment, the decision to excise a wound contaminated with actinides is a risk-benefit analysis. The potential benefits of surgical excision following such contaminated wounds are reduction in the probability of stochastic effects, avoidance of local effects, and psychological comfort knowing that radioactive material deposited in the wound is prevented from being systemic. These benefits should be balanced against the potential risks such as pain, numbness, infection, and loss of function due to excision. To that end, the responsibility of an internal dosimetrist is to provide advice to both the patient and the treating physician about the likely benefits of excision that include, but not limited to, averted doses. This paper provides a review of the effectiveness of surgical excisions following plutonium-contaminated wounds and finds that excisions are highly effective at removing plutonium from wounds and at averting the doses they would have caused.
Collapse
Affiliation(s)
- Deepesh Poudel
- Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM
| | | | | |
Collapse
|
3
|
Glover L, Bertelli L, Dumit S, Poudel D, Smith L, Waters T, Klumpp J. Side Effects and Complications Associated with Treating Plutonium Intakes: A Retrospective Review of the Medical Records of LANL Employees Treated for Plutonium Intakes, with Supplementary Interviews. Health Phys 2022; 123:348-359. [PMID: 35951340 DOI: 10.1097/hp.0000000000001603] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
ABSTRACT Anecdotal evidence indicates there may be unpublished physical and psychological events associated with the medical treatment of plutonium intakes. A thorough review was conducted of the medical and bioassay records of current and previous Los Alamos National Laboratory (LANL) employees who had experienced plutonium intakes via wound or inhalation. After finding relatively incomplete information in the medical records, the research team interviewed current LANL employees who had undergone chelation therapy and/or surgical excision. Although the dataset is not large enough to reach statistically significant conclusions, it was observed that adverse events associated with treatment appear to be more frequent and more severe than previously reported.
Collapse
|
4
|
Beyea J. Implications of Recent Epidemiological Studies for Compensation of Veterans Exposed to Plutonium. Health Phys 2022; 123:133-153. [PMID: 35594489 PMCID: PMC9232282 DOI: 10.1097/hp.0000000000001580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
ABSTRACT The objective of this paper is to compare post-2007 epidemiological results for plutonium workers to risk predicted by the software program NIOSH-IREP (IREP for short), which is used to determine the lowest dose for a US veteran to obtain cancer compensation. IREP output and methodology were used to predict excess relative risk per Gy (ERR Gy -1 ) for lung cancer at the 99 th credibility percentile, which is used for compensation decisions. Also estimated were relative biological effectiveness factors (RBE) predicted for workers using IREP methodology. IREP predictions were compared to results for Mayak and Sellafield plutonium workers, separately and pooled. Indications that IREP might underpredict 99 th -percentile lung cancer plutonium risk came from (1) comparison of worker RBEs and (2) from comparison of Sellafield results separately. When Sellafield and Mayak data were pooled, ERR Gy -1 comparisons at the 99 th percentile roughly matched epidemiological data with regression dose range restricted to < 0.05 Gy, the most relevant region to veterans, but overpredicted for the full dose range. When four plausible distributions for lung cancer risk, including both new and old data, were combined using illustrative weighting factors, compensation cutoff dose for lung cancer matched current IREP values unless regression results below 0.05 were chosen for Sellafield, producing a two-fold reduction. A 1997 claim of a dose threshold in lung cancer dose response was not confirmed in later literature. The benefit of the doubt is given to claimants when the science is unclear. The challenge for NIOSH-IREP custodians is dealing with the Sellafield results, which might best match US claimants.
Collapse
Affiliation(s)
- Jan Beyea
- Senior Scientist, Emeritus, Consulting in the Public Interest, 53 Clinton Street, Lambertville, NJ 08530,
| |
Collapse
|
5
|
Avtandilashvili M, Tolmachev SY. Four-decade follow-up of a plutonium-contaminated puncture wound treated with Ca-DTPA. J Radiol Prot 2021; 41:1122-1144. [PMID: 34034246 DOI: 10.1088/1361-6498/ac04b8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/14/2021] [Accepted: 05/25/2021] [Indexed: 06/12/2023]
Abstract
Contaminated wounds are a common route of internal deposition of radionuclides for nuclear and radiation workers. They may result in significant doses to radiosensitive organs and tissues in an exposed individual's body. The United States Transuranium and Uranium Registries' whole-body donor (Case 0303) accidentally punctured his finger on equipment contaminated with plutonium nitrate. The wound was surgically excised and medically treated with intravenous injections of Ca-DTPA. A total of 16 g Ca-DTPA was administered in 18 treatments during the 2 months following the accident. Ninety-three urine samples were collected and analysed over 14 years following the accident. An estimated239Pu activity of 73.7 Bq was excreted during Ca-DTPA treatment. Post-mortem radiochemical analysis of autopsy tissues indicated that 40 years post-accident 21.6 ± 0.2 Bq of239Pu was retained in the skeleton, 12.2 ± 0.3 Bq in the liver, and 3.7 ± 0.1 Bq in other soft tissues; 1.35 ± 0.02 Bq of239Pu was measured in tissue samples from the wound site. To estimate the plutonium intake, late urine measurements, which were unaffected by chelation, and post-mortem radiochemical analysis results were evaluated using the IMBA Professional Plus software. The application of the National Council on Radiation Protection and Measurements wound model with an assumption of intake material as a predominantly strongly retained soluble plutonium compound with a small insoluble fraction adequately described the data (p= 0.46). The effective intake was estimated to be 50.2 Bq of plutonium nitrate and 1.5 Bq of the fragment. The prompt medical intervention with contaminated tissue excision and subsequent Ca-DTPA decorporation therapy reduced239Pu activity available for uptake and long-term retention in this individual's systemic organs by a factor of 38.
Collapse
Affiliation(s)
- Maia Avtandilashvili
- United States Transuranium and Uranium Registries, Washington State University, Richland, WA, United States of America
| | - Sergei Y Tolmachev
- United States Transuranium and Uranium Registries, Washington State University, Richland, WA, United States of America
| |
Collapse
|
6
|
Akleyev AV, Degteva MO. Radioecological consequences of radioactive releases due to weapons-grade plutonium production at the 'Mayak' facility in the Russian Federation. J Radiol Prot 2021; 41:S67-S79. [PMID: 33494083 DOI: 10.1088/1361-6498/abdfbb] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2020] [Accepted: 01/25/2021] [Indexed: 06/12/2023]
Abstract
The process of nuclear weapons production from 1949 to 1987 was accompanied by the generation of a great amount of radioactive waste. Waste processing operations and controls on discharges at this time were not to the same standard as today. Because of this, vast areas of the Urals region of Russia surrounding the Mayak Production Association (MPA) were exposed to routine and accidental radioactive contamination. The greatest contribution to the contamination was gas aerosol emissions from the MPA in the 1950s (total activity 38 PBq, mainly131I), releases of liquid radioactive waste into the Techa River from 1949 to 1956 (total activity 115 PBq, including long-lived90Sr and137Cs) and accidental atmospheric releases as a result of the thermochemical explosion of the storage tank for liquid radioactive waste in 1957 (74 PBq, relatively short-lived radionuclides being the main contributors). Protective measures helped to relieve the pressing problem of population safety in the 1950s and 1960s, but they led to the appearance of new sources of contamination in the territory surrounding the MPA-Lake Karachay (total activity of beta-emitters 4400 PBq) and the Techa Cascade of Reservoirs (TCR; total activity 8 PBq). Owing to natural radioactive decay and rehabilitation measures, the radiation situation in the East Urals Radioactive Trace (EURT) has improved considerably over the years. Economic activity has been partially restored in these territories. Only the most contaminated territory of the East Urals Radioactive Reserve cannot be used for any economic activities up to the present day. Marked non-uniformity of radioactive contamination of the EURT and the Techa River floodplain, as well as radionuclide washout from Lake Karachay and the TCR into the underground waters and the Techa River require on-going radioecological monitoring, management and regulatory supervision.
Collapse
Affiliation(s)
- A V Akleyev
- Urals Research Center for Radiation Medicine, Chelyabinsk, Russia
- Chelyabinsk State University, Chelyabinsk, Russia
| | - M O Degteva
- Urals Research Center for Radiation Medicine, Chelyabinsk, Russia
| |
Collapse
|
7
|
Abstract
ABSTRACT This whole-body tissue donor to the United States Transuranium and Uranium Registries was occupationally exposed to plutonium nitrate-dioxide mixture via chronic inhalation. This individual was involved in the Manhattan Project operations and later participated in medical follow-up studies. Soft tissues and bones collected at autopsy were analyzed for 238Pu, 239+240Pu, and 241Am. Fifty-three years post-intake, 700±2 Bq of 239+240Pu were still retained in the skeleton, 661±11 Bq in the liver, and 282±3 Bq in the respiratory tract. Bioassay measurements and organ activities at the time of death were used to estimate the intake and radiation doses using the TAURUS internal dosimetry software. For this individual, an ICRP Publication 130 Human Respiratory Tract Model with case-specific particle size of 0.3 μm, ICRP Publication 100 Human Alimentary Tract Model, and ICRP Publication 141 Plutonium Systemic Model adequately described long-term plutonium retention and excretion. The total cumulative 239+240Pu intake of 31,716 Bq was estimated, of which 24,853 Bq (78.4%) were contributed by inhalation of plutonium nitrate and 6,863 Bq (21.6%) of plutonium dioxide. The committed equivalent doses to the red bone marrow, bone surface, liver, lungs, and brain were 0.71 Sv, 6.5 Sv, 8.3 Sv, 3.8 Sv, and 0.068 Sv, respectively. The committed effective dose was 1.22 Sv.
Collapse
Affiliation(s)
- Martin Šefl
- United States Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354-4959
| | | | | |
Collapse
|
8
|
Poudel D, Avtandilashvili M, Bertelli L, Klumpp JA, Tolmachev SY. Long-term Retention of Plutonium in the Respiratory Tracts of Two Acutely-exposed Workers: Estimation of Bound Fraction. Health Phys 2021; 120:258-270. [PMID: 32881734 DOI: 10.1097/hp.0000000000001311] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
ABSTRACT Inhalation of plutonium is a significant contributor of occupational doses in plutonium production, nuclear fuel reprocessing, and cleanup operations. Accurate assessment of the residence time of plutonium in the lungs is important to properly characterize dose and, consequently, the risk from inhalation of plutonium aerosols. This paper discusses the long-term retention of plutonium in different parts of the respiratory tract of two workers who donated their bodies to the US Transuranium and Uranium Registries. The post-mortem tissue radiochemical analysis results, along with the urine bioassay data, were interpreted using Markov Chain Monte Carlo and the latest biokinetic models presented in the Occupational Intakes of Radionuclides series of ICRP publications. The materials inhaled by both workers were found to have solubility between that of plutonium nitrates and oxides. The long-term solubility was also confirmed by comparison of the activity concentration in the lungs and the thoracic lymph nodes. The data from the two individuals can be explained by assuming a bound fraction (fraction of plutonium deposited in the respiratory tract that becomes bound to lung tissue after dissolution) of 1% and 4%, respectively, without having to significantly alter the particle clearance parameters. Effects of different assumptions about the bound fraction on radiation doses to different target regions was also investigated. For inhalation of soluble materials, an assumption of fb of 1%, compared to the ICRP default of 0.2%, increases the dose to the most sensitive target region of the respiratory tract by 258% and that to the total lung by 116%. Some possible alternate methods of explaining higher-than-expected long-term retention of plutonium in the upper respiratory tract of these individuals-such as physical sequestration of material into the scar tissues and possible uptake by lungs-are also briefly discussed.
Collapse
Affiliation(s)
- Deepesh Poudel
- Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM
| | - Maia Avtandilashvili
- US Transuranium and Uranium Registries, Washington State University, Richland, WA
| | - Luiz Bertelli
- Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM
| | - John A Klumpp
- Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM
| | - Sergei Y Tolmachev
- US Transuranium and Uranium Registries, Washington State University, Richland, WA
| |
Collapse
|
9
|
Abstract
NCRP Report 156 describes soluble radionuclide retention kinetics in a wound, segregated into four retention categories: weak (W), moderate (M), strong (S), and avid (A). An alternate single-parameter model, the negative power function, t, is presented in this paper to describe the time behavior of radionuclide retention. With this mathematical description, γ is a single parameter that can be used to assign the wound retention category rapidly. Using the power function description of wound retention, the various wound categories present as straight lines on log scales with different slopes corresponding to the various retention categories. Regression analysis of average retention values in NCRP 156 shows γ = 0.735 ± 0.132, 0.514 ± 0.015, 0.242 ± 0.016, and 0.053 ± 0.023 for the weak, moderate, strong, and avid categories, respectively. A case study is presented (REAC/TS Registry case 1284) where a power function is shown to fit retention data in a Pu/Am hand wound up to 2,000 d (5.4 y) post-accident.
Collapse
|
10
|
Klumpp J, Bertelli L, Dumit S, Gadd M, Poudel D, Waters TL. Response to a Skin Puncture Contaminated with 238Pu at Los Alamos National Laboratory. Health Phys 2020; 119:704-714. [PMID: 33196523 DOI: 10.1097/hp.0000000000001250] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The three principal pathways for intakes of plutonium are ingestion, inhalation, and contaminated wounds. In August 2018, a glovebox worker at Los Alamos National Laboratory (LANL) sustained a puncture from a thread of a braided steel cable contaminated with Pu. The puncture produced no pain, no blood, and little or no visible mark. As a result, the potential for a contaminated wound was not immediately recognized, and a wound count was not conducted until elevated urine bioassay results were received 12 d after the incident. This paper discusses the circumstances of the incident, along with the medical response and dose assessment, and a discussion of the risks and benefits of the medical interventions.
Collapse
Affiliation(s)
- John Klumpp
- Los Alamos National Laboratory, Radiation Protection Division, MS G761, Los Alamos, NM 87545
| | | | | | | | | | | |
Collapse
|
11
|
Poudel D, Klumpp JA, Bertelli L, Dumit S, Waters TL. Dose Assessment Following a 238Pu-contaminated Wound Case with Chelation and Excision. Health Phys 2020; 119:690-703. [PMID: 33196522 DOI: 10.1097/hp.0000000000001202] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The urinary excretion and wound retention data collected after a Pu-contaminated wound were analyzed using Markov Chain Monte Carlo (MCMC) to obtain the posterior distribution of the intakes and doses. An empirical approach was used to model the effects of medical treatments (chelation and excision) on the reduction of doses. It was calculated that DTPA enhanced the urinary excretion, on average, by a factor of 17. The empirical analysis also allowed calculation of the efficacies of the medical treatments-excision and chelation averted approximately 76% and 5.5%, respectively, of the doses that would have been if there were no medical treatment. All bioassay data are provided in the appendix for independent analysis and to facilitate the compartmental modeling approaches being developed by the health physics community.
Collapse
|
12
|
Dumit S, Miller G, Klumpp JA, Poudel D, Bertelli L, Waters TL. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA. Health Phys 2020; 119:715-732. [PMID: 33196524 DOI: 10.1097/hp.0000000000001282] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
The administration of chelation therapy to treat significant intakes of actinides, such as plutonium, affects the actinide's normal biokinetics. In particular, it enhances the actinide's rate of excretion, such that the standard biokinetic models cannot be applied directly to the chelation-affected bioassay data in order to estimate the intake and assess the radiation dose. The present study proposes a new chelation model that can be applied to the chelation-affected bioassay data after plutonium intake via wound and treatment with DTPA. In the proposed model, chelation is assumed to occur in the blood, liver, and parts of the skeleton. Ten datasets, consisting of measurements of C-DTPA, Pu, and Pu involving humans given radiolabeled DTPA and humans occupationally exposed to plutonium via wound and treated with chelation therapy, were used for model development. The combined dataset consisted of daily and cumulative excretion (urine and feces), wound counts, measurements of excised tissue, blood, and post-mortem tissue analyses of liver and skeleton. The combined data were simultaneously fit using the chelation model linked with a plutonium systemic model, which was linked to an ad hoc wound model. The proposed chelation model was used for dose assessment of the wound cases used in this study.
Collapse
Affiliation(s)
- Sara Dumit
- Los Alamos National Laboratory Los Alamos, NM
| | - Guthrie Miller
- Los Alamos National Laboratory, Radiation Protection Division, MS G761, Los Alamos, NM 87545
| | | | | | | | | |
Collapse
|
13
|
Azimzadeh O, Azizova T, Merl-Pham J, Blutke A, Moseeva M, Zubkova O, Anastasov N, Feuchtinger A, Hauck SM, Atkinson MJ, Tapio S. Chronic Occupational Exposure to Ionizing Radiation Induces Alterations in the Structure and Metabolism of the Heart: A Proteomic Analysis of Human Formalin-Fixed Paraffin-Embedded (FFPE) Cardiac Tissue. Int J Mol Sci 2020; 21:ijms21186832. [PMID: 32957660 PMCID: PMC7555548 DOI: 10.3390/ijms21186832] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2020] [Revised: 09/14/2020] [Accepted: 09/14/2020] [Indexed: 12/23/2022] Open
Abstract
Epidemiological studies on workers employed at the Mayak plutonium enrichment plant have demonstrated an association between external gamma ray exposure and an elevated risk of ischemic heart disease (IHD). In a previous study using fresh-frozen post mortem samples of the cardiac left ventricle of Mayak workers and non-irradiated controls, we observed radiation-induced alterations in the heart proteome, mainly downregulation of mitochondrial and structural proteins. As the control group available at that time was younger than the irradiated group, we could not exclude age as a confounding factor. To address this issue, we have now expanded our study to investigate additional samples using archival formalin-fixed paraffin-embedded (FFPE) tissue. Importantly, the control group studied here is older than the occupationally exposed (>500 mGy) group. Label-free quantitative proteomics analysis showed that proteins involved in the lipid metabolism, sirtuin signaling, mitochondrial function, cytoskeletal organization, and antioxidant defense were the most affected. A histopathological analysis elucidated large foci of fibrotic tissue, myocardial lipomatosis and lymphocytic infiltrations in the irradiated samples. These data highlight the suitability of FFPE material for proteomics analysis. The study confirms the previous results emphasizing the role of adverse metabolic changes in the radiation-associated IHD. Most importantly, it excludes age at the time of death as a confounding factor.
Collapse
Affiliation(s)
- Omid Azimzadeh
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Institute of Radiation Biology, 85764 Neuherberg, Germany; (N.A.); (M.J.A.); (S.T.)
- Correspondence: ; Tel.: +49-89-3187-3887
| | - Tamara Azizova
- Southern Urals Biophysics Institute (SUBI), Russian Federation, 456780 Ozyorsk, Russia; (T.A.); (M.M.); (O.Z.)
| | - Juliane Merl-Pham
- Helmholtz Zentrum München—German Research Centre for Environmental Health, Research Unit Protein Science, 80939 Munich, Germany; (J.M.-P.); (S.M.H.)
| | - Andreas Blutke
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Research Unit Analytical Pathology, 85764 Neuherberg, Germany; (A.B.); (A.F.)
| | - Maria Moseeva
- Southern Urals Biophysics Institute (SUBI), Russian Federation, 456780 Ozyorsk, Russia; (T.A.); (M.M.); (O.Z.)
| | - Olga Zubkova
- Southern Urals Biophysics Institute (SUBI), Russian Federation, 456780 Ozyorsk, Russia; (T.A.); (M.M.); (O.Z.)
| | - Natasa Anastasov
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Institute of Radiation Biology, 85764 Neuherberg, Germany; (N.A.); (M.J.A.); (S.T.)
| | - Annette Feuchtinger
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Research Unit Analytical Pathology, 85764 Neuherberg, Germany; (A.B.); (A.F.)
| | - Stefanie M. Hauck
- Helmholtz Zentrum München—German Research Centre for Environmental Health, Research Unit Protein Science, 80939 Munich, Germany; (J.M.-P.); (S.M.H.)
| | - Michael J. Atkinson
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Institute of Radiation Biology, 85764 Neuherberg, Germany; (N.A.); (M.J.A.); (S.T.)
- Chair of Radiation Biology, Technical University of Munich, 81675 Munich, Germany
| | - Soile Tapio
- Helmholtz Zentrum München—German Research Centre for Environmental Health GmbH, Institute of Radiation Biology, 85764 Neuherberg, Germany; (N.A.); (M.J.A.); (S.T.)
| |
Collapse
|
14
|
Griffiths NM, Van der Meeren A, Angulo JF, Vincent-Naulleau S. Research on the Radiotoxicology of Plutonium Using Animals: Consideration of the 3Rs-Replace, Reduce, Refine. Health Phys 2020; 119:133-140. [PMID: 32301862 DOI: 10.1097/hp.0000000000001258] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
To characterize the health effects of incorporated plutonium, many experiments have been conducted using different animal models. These range from (1) applied (tissue uptake/retention determination, decorporation therapy efficacy), (2) fundamental (gene expression, cancer induction), and (3) dosimetry models. In recent years, the use of animals for scientific purposes has become a public concern. The application of the 3Rs - Replace (use of alternative methods or animals not considered capable of experiencing pain, suffering, and distress), Reduce (reduction in animal numbers), and Refine (better animal welfare and minimization of suffering, pain and distress) - has increased to address ethical concerns and legislative requirements. The introduction of novel non-animal technologies is also an important factor as complementary options to animal experimentation. In radiotoxicology research, it seems there is a natural tendency to Replace given the possibility of data reuse obtained from contamination cases in man and animal studies. The creation of "registries" and "repositories" for nuclear industry workers (civil and military) is now a rich legacy for radiotoxicological measurements. Similarly, Reduction in animal numbers can be achieved by good experimental planning with prior statistical analyses of animal numbers required to obtain robust data. Multiple measurements in the same animal over time (external body counting, excreta collection) with appropriate detection instruments also allow Reduction. In terms of Refinement, this has become "de rigueur" and a necessity given the societal and legal concerns for animal welfare. For research in radiotoxicology, particularly long-term studies, better housing conditions within the constraints of radiation protection issues for research workers are an important concern. These are all pertinent considerations for the 3Rs remit and future research in radiotoxicology.
Collapse
Affiliation(s)
- Nina M Griffiths
- Laboratoire de RadioToxicologie, CEA, Université Paris-Saclay, Bruyères-le-Châtel, 91297 ARPAJON, France
| | - Anne Van der Meeren
- Laboratoire de RadioToxicologie, CEA, Université Paris-Saclay, Bruyères-le-Châtel, 91297 ARPAJON, France
| | - Jaime F Angulo
- Laboratoire de RadioToxicologie, CEA, Université Paris-Saclay, Bruyères-le-Châtel, 91297 ARPAJON, France
| | - Silvia Vincent-Naulleau
- Bureau des Etudes Biomédicales chez l'Animal, CEA/DRF/D3P/BEBA, 92260 FONTENAY-aux-ROSES, France
| |
Collapse
|
15
|
Zhuntova GV, Azizova TV, Grigoryeva ES. Risk of stomach cancer incidence in a cohort of Mayak PA workers occupationally exposed to ionizing radiation. PLoS One 2020; 15:e0231531. [PMID: 32294114 PMCID: PMC7159243 DOI: 10.1371/journal.pone.0231531] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2019] [Accepted: 03/25/2020] [Indexed: 12/17/2022] Open
Abstract
Stomach cancer is a widespread health condition associated with environmental and genetic factors. Contribution of ionizing radiation to stomach cancer etiology is not sufficiently studied. This study was aimed to assess an association of the stomach cancer incidence risk with doses from occupational radiation exposure in a cohort of workers hired at main Mayak production association facilities in 1948–1982 taking into account non-radiation factors including digestive disorders. The study cohort comprised 22,377 individuals and by 31.12.2013 343 stomach cancer diagnoses had been reported among the cohort members. Occupational stomach absorbed doses were provided by the Mayak Worker Dosimetry System– 2008 (MWDS–2008) for external gamma ray exposure and by the Mayak Worker Dosimetry System– 2013 (MWDS–2013) for internal exposure to plutonium. Excess relative risks (ERR) per Gy for stomach cancer were estimated using the Poisson’s regression. Analyses were run using the AMFIT module of the EPICURE software. The stomach cancer incidence risk in the study cohort was found to be significantly associated with the stomach absorbed dose of gamma rays: ERR/Gy = 0.19 (95% CI: 0.01, 0.44) with a 0 year lag, and ERR/Gy = 0.20 (95% CI: 0.01, 0.45) with a 5 year lag. To estimate the baseline risk, sex, attained age, smoking status and alcohol consumption, chronic diseases (peptic ulcer, gastritis and duodenitis) were taken into account. No modifications of the radiogenic risk by non-radiation factors were found in the study worker cohort. No association of the stomach cancer incidence risk with internal exposure to incorporated plutonium was observed.
Collapse
Affiliation(s)
- Galina V. Zhuntova
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| | - Tamara V. Azizova
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
- * E-mail:
| | - Evgeniya S. Grigoryeva
- Clinical Department, Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk region, Russia
| |
Collapse
|
16
|
Azizova T, Moseeva M, Grigoryeva E, Zhuntova G, Bannikova M, Sychugov G, Kazachkov E. Registry of Plutonium-induced Lung Fibrosis in a Russian Nuclear Worker Cohort. Health Phys 2020; 118:185-192. [PMID: 31833971 DOI: 10.1097/hp.0000000000001131] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
A registry of plutonium-induced lung fibrosis diagnosed in members of a cohort of the first Russian nuclear industry facility Mayak Production Association was established. The registry includes 188 plutonium-induced lung fibrosis diagnoses: 117 (62.23%) in males and 71 (37.77%) in females. This paper describes the structure and detailed characteristics of the registry. Plutonium-induced lung fibrosis was shown to have no association with cumulative lung absorbed dose from external gamma rays as of the date of diagnosis. On the contrary, the plutonium-induced lung fibrosis rate was shown to be associated with cumulative lung absorbed dose from incorporated alpha particles and to increase significantly with increasing dose from internal radiation exposure. This paper discusses potential applications of the registry to scientific investigations in the future.
Collapse
Affiliation(s)
- Tamara Azizova
- Federal State Unitary Enterprise, Southern Urals Biophysics Institute at the Federal Medical Biological Agency of the Russian Federation
| | - Maria Moseeva
- Federal State Unitary Enterprise, Southern Urals Biophysics Institute at the Federal Medical Biological Agency of the Russian Federation
| | - Evgeniya Grigoryeva
- Federal State Unitary Enterprise, Southern Urals Biophysics Institute at the Federal Medical Biological Agency of the Russian Federation
| | - Galina Zhuntova
- Federal State Unitary Enterprise, Southern Urals Biophysics Institute at the Federal Medical Biological Agency of the Russian Federation
| | - Maria Bannikova
- Federal State Unitary Enterprise, Southern Urals Biophysics Institute at the Federal Medical Biological Agency of the Russian Federation
| | - Gleb Sychugov
- State Educational Institution of Higher Professional Education, South Ural State Medical University at the Ministry of Health of the Russian Federation
| | - Evgeny Kazachkov
- State Educational Institution of Higher Professional Education, South Ural State Medical University at the Ministry of Health of the Russian Federation
| |
Collapse
|
17
|
Vostrotin VV, Napier BA, Zhdanov AV, Miller SC, Sokolova AB, Bull RK, Suslova KG, Efimov AV, Smith MA, Vvedensky VE. THE MAYAK WORKER DOSIMETRY SYSTEM (MWDS-2016): INTERNAL DOSIMETRY RESULTS AND COMPARISON WITH MWDS-2013. Radiat Prot Dosimetry 2019; 184:201-210. [PMID: 30496515 DOI: 10.1093/rpd/ncy200] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Revised: 10/22/2018] [Accepted: 11/12/2018] [Indexed: 06/09/2023]
Abstract
Differences in results from the new Mayak Worker Dosimetry System (MWDS-2016) vs the previous MWDS-2013 are described. Statistical characteristics are shown for the distribution of accumulated absorbed doses to organs for 8340 workers with bioassay data. Differences in mean values of accumulated doses and their relative standard uncertainties calculated by MWDS-2016 and MWDS-2013 were analysed separately for various types of industrial compounds of plutonium, specifically nitrates, mixtures and oxides. Within the range of accumulated doses >1 mGy, lung doses for nitrates and mixtures decreased by 41 and 15%, respectively, and remained at the same level for oxides. Accumulated liver doses within the range >1 mGy increased for nitrates and mixtures by 13 and 8%, respectively, and decreased for oxides by 7%.
Collapse
Affiliation(s)
- Vadim V Vostrotin
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| | - Bruce A Napier
- Pacific Northwest National Laboratory, Richland, WA, USA
| | - Alexei V Zhdanov
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| | | | - Alexandra B Sokolova
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| | | | - Klara G Suslova
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| | - Alexander V Efimov
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| | | | - Vladimir E Vvedensky
- Southern Urals Biophysics Institute (SUBI), Ozyorskoe Shosse 19, Ozyorsk, Chelyabinsk Region, Russia
| |
Collapse
|
18
|
Tolmachev SY, Swint MJ, Bistline RW, McClellan RO, McInroy JF, Kathren RL, Filipy RE, Toohey RE. USTUR Special Session Roundtable-US Transuranium and Uranium Registries (USTUR): A Five-decade Follow-up of Plutonium and Uranium Workers. Health Phys 2019; 117:211-222. [PMID: 31219903 DOI: 10.1097/hp.0000000000001105] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The US Transuranium and Uranium Registries is a human tissue program that collects tissues posthumously from former nuclear workers and radiochemically analyzes them for actinides such as plutonium, americium, and uranium. It was established in 1968 with the goal of advancing science and improving the safety of future workers. Roundtable participants recalled various aspects of this multidisciplinary research program, from establishing consistent autopsy protocols to comparing the registries' findings to those of other programs, such as the historical beagle dog studies and the Russian Radiobiological Human Tissue Repository. The importance of meeting ethical and legal requirements, including written consent forms, was emphasized, as was the need to know whether workers were exposed to nonradiological hazards such as beryllium or asbestos. At Rocky Flats, a bioassay program was established to follow workers after they terminated employment. The resulting data continue to help researchers to improve the biokinetic models that are used to estimate intakes and radiation doses. After 50 y, the US Transuranium and Uranium Registries continues to contribute to our understanding of actinides in humans, which is a testament to the vision of its founders, the generosity of its tissue donors, and the many dedicated scientists who have worked together to achieve a common goal.
Collapse
Affiliation(s)
- Sergei Y Tolmachev
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | - Margery J Swint
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | - Robert W Bistline
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | - Roger O McClellan
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | - James F McInroy
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | - Ronald L Kathren
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| | | | - Richard E Toohey
- US Transuranium and Uranium Registries, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA 99354
| |
Collapse
|
19
|
Riddell A, Wakeford R, Liu H, O'Hagan J, MacGregor D, Agius R, Wilson C, Peace M, de Vocht F. Building a job-exposure matrix for early plutonium workers at the Sellafield nuclear site, United Kingdom. J Radiol Prot 2019; 39:620-634. [PMID: 31112514 DOI: 10.1088/1361-6498/ab1168] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The potential for adverse health effects from internal exposure to Plutonium has been recognised since its discovery in the 1940s. However, in the absence of specific information, potential risks from Plutonium exposure have always largely been controlled through knowledge of radiation exposure risks in general, much of which comes from external radiation exposures. To try to obtain more direct estimates of potential internal exposure risks, epidemiological studies of Plutonium workers need to be conducted. Such epidemiological analyses require individual Plutonium exposure estimates that are as accurate and unbiased as possible. The UK Sellafield workforce includes one of the world's largest cohorts of Plutonium workers, which constitutes, by some considerable margin, the group of workers most comprehensively monitored for internal exposure to this alpha-particle-emitter. However, for several hundred workers employed at the start of Plutonium work at the facility, during the period from 1952 through to 1963, the historical urinalysis results available cannot provide sufficiently accurate and unbiased exposure assessments needed for use in epidemiological studies. Consequently, these early workers have had to be excluded from epidemiological analyses and this has significantly reduced the power of these studies. A promising quantitative methodology to overcome the issue of missing or deficient exposure data, is to use exposure data from other sources to estimate the average exposure a 'typical worker' would have received, and to collate this information for specific occupations and years. This approach is called a Job-Exposure Matrix (JEM). Work on a pilot study to construct a population-specific quantitative JEM for the early Plutonium workers at Sellafield during 1952-1963, for whom reliable urinalysis results do not exist, has shown the potential for a JEM approach to produce more reliable and useful exposure estimates for epidemiological research.
Collapse
Affiliation(s)
- Anthony Riddell
- Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Public Health England, Didcot, OX11 0RQ, The United Kingdom
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Tatsuzaki H, Tominaga T, Kim E, Watanabe S, Tsutsumi Y, Sagara M, Takada C, Momose T, Kurihara O, Akashi M. AN ACCIDENT OF INTERNAL CONTAMINATION WITH PLUTONIUM AND AMERICIUM AT A NUCLEAR FACILITY IN JAPAN: A PRELIMINARY REPORT AND THE POSSIBILITY OF DTPA ADMINISTRATION ADDING TO THE DIAGNOSIS. Radiat Prot Dosimetry 2018; 182:98-103. [PMID: 30165696 DOI: 10.1093/rpd/ncy145] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/30/2018] [Indexed: 06/08/2023]
Abstract
This article introduces the first accident of internal contamination with plutonium (Pu) or americium (Am) in Japan for which treatment was carried out. An accident of internal contamination with Pu and Am occurred at a Pu research facility at Oarai-town of Ibaraki prefecture in Japan. A plastic bag containing these radionuclides ruptured when five workers were inspecting a storage container in a hood. As a consequence, these workers were internally contaminated with Pu and Am. Although contamination on the body surface was observed in all five workers, a positive nasal swab was detected in only three of them. A chelating agent, calcium diethylenetriaminepenta-acetate (CaDTPA), was administered to all of them including the two workers without a positive nasal swab. However, bioassay detected a significant amount of Pu and Am in urine after administration of DTPA in these two workers, whereas the levels of these nuclides were below minimum detectable levels in urine before the administration. Since the prevalence of adverse reactions in DTPAs is low, the present results suggest that administration of DTPA can be used for the diagnosis of internal contamination even when a nasal swab is negative or contamination around body orifices is not detected.
Collapse
Affiliation(s)
- Hideo Tatsuzaki
- Radiation Emergency Medicine Center, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan
| | - Takako Tominaga
- Radiation Emergency Medicine Center, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan
| | - Eunjoo Kim
- Department of Radiation Measurement and Dose Assessment, NIRS, QST, Japan
| | - Sadahiro Watanabe
- Radiation Emergency Medicine Center, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan
| | - Yayoi Tsutsumi
- Radiation Emergency Medicine Center, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan
| | - Masashi Sagara
- Radiation Emergency Medicine Center, National Institute of Radiological Sciences (NIRS), National Institutes for Quantum and Radiological Science and Technology (QST), 4-9-1 Anagawa, Inage-ku, Chiba-city, Chiba, Japan
| | - Chie Takada
- Nuclear Fuel Cycle Engineering Laboratories (NCL), Japan Atomic Energy Agency (JAEA), 4-33 Muramatsu, Tokai-mura, Naka-gun, Ibaraki, Japan
| | - Takumaro Momose
- Nuclear Fuel Cycle Engineering Laboratories (NCL), Japan Atomic Energy Agency (JAEA), 4-33 Muramatsu, Tokai-mura, Naka-gun, Ibaraki, Japan
| | - Osamu Kurihara
- Department of Radiation Measurement and Dose Assessment, NIRS, QST, Japan
| | | |
Collapse
|
21
|
Chen S, Ko R, Lai EPC, Wyatt H, Abergel RJ, Li C. ENCAPSULATED 3,4,3-LI(1,2-HOPO) IN CHITOSAN NANOPARTICLES FOR DECORPORATION VIA INHALATION. Radiat Prot Dosimetry 2018; 182:107-111. [PMID: 30165556 DOI: 10.1093/rpd/ncy139] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
3,4,3-LI(1,2-HOPO) has been identified as an excellent alternative for DTPA for decorporating actinides, such as Pu and Am, after internal contamination. Efforts have been focused on its application through oral administration. When 3,4,3-LI(1,2-HOPO) was encapsulated with biocompatible, biodegradable nanoparticles made of chitosan, its release from the nanoparticles to lung fluid, observed in in vitro experiments, exhibited an extended release profile. These observations were very encouraging, as this nanomedicine could lead to a reduction in the dosing frequency required to achieve the decorporation efficacy of unformulated 3,4,3-LI(1,2-HOPO) itself. In vivo release tests as well as actinide decorporation experiments, using an inhalation exposure animal model, will follow.
Collapse
Affiliation(s)
- Sijing Chen
- Department of Chemistry, Carleton University, Ottawa, Canada
| | - Raymond Ko
- Radiation Protection Bureau, Health Canada, Ottawa, Canada
| | - Edward P C Lai
- Department of Chemistry, Carleton University, Ottawa, Canada
| | | | - Rebecca J Abergel
- Chemical Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, USA
| | - Chunsheng Li
- Department of Chemistry, Carleton University, Ottawa, Canada
| |
Collapse
|
22
|
Sugarman SL, Findley WM, Toohey RE, Dainiak N. Rapid Response, Dose Assessment, and Clinical Management of a Plutonium-contaminated Puncture Wound. Health Phys 2018; 115:57-64. [PMID: 29787431 DOI: 10.1097/hp.0000000000000821] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Internalization of radionuclides occurs not only by inhalation, ingestion, parenteral injection (i.e., administration of radioactive material for a medical purpose), and direct transdermal absorption, but also by contaminated wounds. In June 2010, a glove-box operator at the U.S. Department of Energy's Savannah River Site sustained a puncture wound while venting canisters containing legacy materials contaminated with Pu. To indicate the canisters had been vented, a flag was inserted into the vent hole. The shaft of the flag penetrated the protective gloves worn by the operator. Initial monitoring performed with a zinc-sulfide alpha detector indicated 300 dpm at the wound site. After being cleared by radiological controls personnel, the patient was taken to the site medical facility where decontamination was attempted and diethylenetriaminepentaacetic acid (DTPA) was administered intravenously within 1.5 h of the incident. The patient was then taken to the Savannah River Site In Vivo Counting Facility where the wound was counted with a Canberra GL 2820 high-purity germanium detector, capable of quantifying contamination by detecting low-energy x rays and gamma rays. In addition to the classic 13, 17, and 20 keV photons associated with Pu, the low-yield (0.04%) 43.5 keV peak was also detected. This indicated a level of wound contamination orders of magnitude above the initial estimate of 300 dpm detected with handheld instrumentation. Trace quantities of Am were also identified via the 59.5 keV peak. A 24 h urine sample collection was begun on day 1 and continued at varying intervals for over a year. The patient underwent a punch biopsy at 3 h postincident (14,000 dpm removed) and excisional biopsies on days 1 and 9 (removal of an additional 3,200 dpm and 3,800 dpm, respectively). The initial post-DTPA urine sample analysis report indicated excretion in excess of 24,000 dpm Pu. Wound mapping was performed in an effort to determine migration from the wound site and indicated minimum local migration. In vivo counts were performed on the liver, axillary lymph nodes, supratrochlear lymph nodes, and skeleton to assess uptake and did not indicate measurable activity. Seventy-one total doses of DTPA were administered at varying frequencies for 317 d post intake. After allowing 100 d for removal of DTPA from the body, five 24 h urine samples were collected and analyzed for dose assessment by using the wound model described in National Council on Radiation Protection and Measurements Report No. 156. The total effective dose averted via physical removal of the contaminant and DTPA administration exceeded 1 Sv, demonstrating that rapid recognition of incident magnitude and prompt medical intervention are critical for dose aversion.
Collapse
Affiliation(s)
| | | | - Richard E Toohey
- MH Chew and Associates, 7633 Southfront Rd., Suite 170, Livermore, CA 94551
| | | |
Collapse
|
23
|
Abstract
The International Commission on Radiological Protection (ICRP) mandated a task group (Task Group 64) to review recently published epidemiological studies related to cancer risk and incorporated alpha emitters, and to evaluate whether the results might consolidate or challenge assumptions underlying the current radiation protection system. Three major alpha emitters were considered: radon and its decay products, plutonium, and uranium. Results came mainly from cohorts of workers, while for radon, major studies of the general population contributed to a better understanding of the risk of lung cancer at low and chronic exposure. Selection criteria for the review were: assessment of individual exposure of the target organ, long duration of the health survey, availability of attained age at end of follow-up, and adjustment for major co-factors. Task Group 64 is composed of members from ICRP Committees 1 and 2 (because epidemiological and dosimetric expertise were needed) and external experts. A first report (ICRP Publication 115) considered the risk of lung cancer related to inhalation of radon and its decay products. As the estimated excess risk per unit of exposure was higher by a factor of 2 compared with a previous ICRP estimate in 1993, Task Group 64 suggested a reconsideration of the reference levels for the workplace and for the general population. A second report, using the same standardised methodology (lung cancer baselines, population, life expectancy), will include estimation of the cancer risk of nuclear workers exposed to plutonium, focusing on the risk of lung cancer. A comparison of these risks with those of populations exposed to external gamma radiation alone will be made in the near future. For uranium, the results related to the organ-specific dose were too sparse to draw reliable conclusions, despite a recent publication. More research is needed on this topic.
Collapse
Affiliation(s)
- M Tirmarche
- Nuclear Safety Authority, ASN, 15, rue Louis Lejeune, 92541 Montrouge, France
| |
Collapse
|
24
|
Abstract
During the aftermath of a radiological accident or attack, the rapid identification of individuals who have internalized medically significant amounts of material is paramount to guide medical and public health decisions. This paper explores the utility of hand-held, pancake GM detectors to determine if an individual has inhaled Sr, Cs, Pu, Pu, or Am in quantities requiring treatment. Additionally, ingestion of Sr or Cs was considered. Both Sr and Cs were modeled in equilibrium with their progeny, but the progeny of Pu, Pu, and Am were excluded. Treatment thresholds are defined using the National Council on Radiation Protection & Measurements' (NCRP) clinical decision guides (CDGs). Using Monte Carlo N-Particle (MCNP) modeling software, a human phantom and detector were modeled to determine the activity required to achieve a detector reading of twice background 1, 7, or 30 d post-ingestion or post-inhalation. Modeling found that inhaled Pu, Pu, and Am are detectable only if the contaminated individual inhaled thousands-fold more material than the CDG. This lack of detectability means that hand-held GM detectors are inappropriate for initial screening for americium or plutonium and that more intensive screening is necessary to confirm suspected contamination. Cesium-137, by contrast, could be detected at levels 10- to 100-fold lower than the amount requiring treatment, allowing quick differentiation between contaminated and uncontaminated individuals. Surprisingly, Sr was detectable within a factor of 2 of the amount requiring treatment. Detection of Sr was due primarily to bremsstrahlung radiation from beta interactions with calcium in bone. While rapid screening could identify individuals contaminated by Cs and possibly with Sr, further screening of identified individuals is necessary to establish medical need. However, these contaminated individuals could still be prioritized for further testing and possible presumptive treatment. Based on the findings of this study, concepts of operation for the use of hand-held survey meters should be developed for the screening of individuals potentially internally contaminated with Cs and Sr.
Collapse
|
25
|
Poudel D, Bertelli L, Klumpp JA, Waters TL. Some Considerations for Chelation Treatment and Surgical Excision Following Incorporation of Plutonium in Wounds. Health Phys 2018; 114:307-318. [PMID: 29360709 DOI: 10.1097/hp.0000000000000772] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
After a plutonium-contaminated wound, the role of an internal dosimetrist is to inform the patient and the physician of the dosimetric considerations. The doses averted due to medical treatments (excision or chelation) are higher if the treatments are administered early; therefore, the internal dosimetrist needs to rely on limited information on wound counts and process knowledge for advising the physician. Several wound cases in the literature were reviewed to obtain estimates of the efficacies of surgical excision and chelation treatment after plutonium-contaminated wounds. The dose coefficients calculated by coupling the NCRP 156 wound model with the systemic model were used to derive the decision guidelines that may indicate medical treatment based on 1) the concept of saved doses proposed by the NCRP 156 wound model, 2) the limits recommended by the CEC/DOE guidebook, and 3) the Clinical Decision Guidelines proposed in NCRP Report No. 161. These guidelines by themselves, however, are of limited use for several reasons, including 1) large uncertainties associated with wound measurements, 2) exposure to forms of radionuclides that cannot be assigned to a single category in the NCRP 156 framework, 3) inability of the NCRP 156 model to explain some of the wound cases in the literature, 4) neglect of the local doses to the wound site and the pathophysiological response of the tissue, 5) poorly understood relationship between effective doses and risks of late health effects, and 6) disregard of the psychological aspects of radionuclide intake.
Collapse
Affiliation(s)
- Deepesh Poudel
- *Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM 87545
| | | | | | | |
Collapse
|
26
|
Poudel D, Guilmette RA, Klumpp JA, Bertelli L, Waters TL. Application of NCRP 156 Wound Models for the Analysis of Bioassay Data from Plutonium Wound Cases. Health Phys 2017; 113:209-219. [PMID: 28749811 DOI: 10.1097/hp.0000000000000694] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The NCRP 156 wound model was heavily based on data from animal experiments. The authors of the report acknowledged this limitation and encouraged validation of the models using data from human wound exposures. The objective of this paper was to apply the NCRP 156 wound models to the bioassay data from four plutonium-contaminated wound cases reported in the literature. Because a wide variety of forms of plutonium can be expected at a nuclear facility, a combination of the wound models-rather than a single model-was used to successfully explain both the urinary excretion data and wound retention data in three cases. The data for the fourth case could not be explained by any combination of the default wound models. While this may possibly be attributed to the existence of a category of plutonium whose solubility and chemistry are different than those described by the NCRP 156 default categories, the differences may also be the result of differences in systemic biokinetics. The concept of using a combination of biokinetic models may be extended to inhalation exposures as well, where more than one form of radionuclide-particles of different solubility or different sizes-may exist in a workplace.
Collapse
Affiliation(s)
- Deepesh Poudel
- *Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM 87545; †Ray Guilmette and Associates, LLC, Perry, ME
| | | | | | | | | |
Collapse
|
27
|
Grellier J, Atkinson W, Bérard P, Bingham D, Birchall A, Blanchardon E, Bull R, Guseva Canu I, Challeton-de Vathaire C, Cockerill R, Do MT, Engels H, Figuerola J, Foster A, Holmstock L, Hurtgen C, Laurier D, Puncher M, Riddell AE, Samson E, Thierry-Chef I, Tirmarche M, Vrijheid M, Cardis E. Risk of Lung Cancer Mortality in Nuclear Workers from Internal Exposure to Alpha Particle-emitting Radionuclides. Epidemiology 2017; 28:675-684. [PMID: 28520643 PMCID: PMC5540354 DOI: 10.1097/ede.0000000000000684] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2016] [Accepted: 05/15/2017] [Indexed: 11/26/2022]
Abstract
BACKGROUND Carcinogenic risks of internal exposures to alpha-emitters (except radon) are poorly understood. Since exposure to alpha particles-particularly through inhalation-occurs in a range of settings, understanding consequent risks is a public health priority. We aimed to quantify dose-response relationships between lung dose from alpha-emitters and lung cancer in nuclear workers. METHODS We conducted a case-control study, nested within Belgian, French, and UK cohorts of uranium and plutonium workers. Cases were workers who died from lung cancer; one to three controls were matched to each. Lung doses from alpha-emitters were assessed using bioassay data. We estimated excess odds ratio (OR) of lung cancer per gray (Gy) of lung dose. RESULTS The study comprised 553 cases and 1,333 controls. Median positive total alpha lung dose was 2.42 mGy (mean: 8.13 mGy; maximum: 316 mGy); for plutonium the median was 1.27 mGy and for uranium 2.17 mGy. Excess OR/Gy (90% confidence interval)-adjusted for external radiation, socioeconomic status, and smoking-was 11 (2.6, 24) for total alpha dose, 50 (17, 106) for plutonium, and 5.3 (-1.9, 18) for uranium. CONCLUSIONS We found strong evidence for associations between low doses from alpha-emitters and lung cancer risk. The excess OR/Gy was greater for plutonium than uranium, though confidence intervals overlap. Risk estimates were similar to those estimated previously in plutonium workers, and in uranium miners exposed to radon and its progeny. Expressed as risk/equivalent dose in sieverts (Sv), our estimates are somewhat larger than but consistent with those for atomic bomb survivors.See video abstract at, http://links.lww.com/EDE/B232.
Collapse
Affiliation(s)
- James Grellier
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Will Atkinson
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Philippe Bérard
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Derek Bingham
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Alan Birchall
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Eric Blanchardon
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Richard Bull
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Irina Guseva Canu
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Cécile Challeton-de Vathaire
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Rupert Cockerill
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Minh T. Do
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Hilde Engels
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Jordi Figuerola
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Adrian Foster
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Luc Holmstock
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Christian Hurtgen
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Dominique Laurier
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Matthew Puncher
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Anthony E. Riddell
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Eric Samson
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Isabelle Thierry-Chef
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Margot Tirmarche
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Martine Vrijheid
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| | - Elisabeth Cardis
- From the ISGlobal, Centre for Research in Environmental Epidemiology, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain; Department of Epidemiology and Biostatistics, Imperial College, London, United Kingdom; Nuvia Limited, Didcot, United Kingdom; Commissariat à l’Energie Atomique, Fontenay-aux-Roses, France; Atomic Weapons Establishment, Aldermaston, United Kingdom; Public Health England, Didcot & Moor Row, United Kingdom; Institut de Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, France; Institut de Veille Sanitaire, Saint Maurice, France; Occupational Cancer Research Centre, Toronto, ON, Canada; Studiecentrum voor Kernenergie • Centre d’Étude de l’énergie Nucléaire, Mol, Belgium; UK Atomic Energy Authority, Culham, United Kingdom; Autorité de Sûreté Nucléaire, Paris, France; and International Agency for Research on Cancer, Lyon, France
| |
Collapse
|
28
|
Abstract
Small, highly radioactive fragments of material incorporated into metallic matrices are commonly found at nuclear weapons test and accident sites and can be inhaled by wildlife. Inhaled particles often partition heterogeneously in the lungs, with aggregation occurring in the periphery of the lung, and are tenaciously retained. However, dose rates are typically calculated as if the material were homogeneously distributed throughout the entire organ. Here the authors quantify the variation in dose rates for alpha-, beta-, and gamma-emitting radionuclides with particle sizes from 0.01-150 μm (alpha) and 1-150 μm (beta, gamma) and considering three averaging volumes-the entire lung (64 cm), a 10-cm volume of tissue, and a 1-cm volume of tissue. Dose rates from beta-emitting particles (e.g., Sr) were approximately one order of magnitude higher than those from gamma-emitting radionuclides (e.g., Cs). Self-shielding within the particle, which reduces the dose rate to the surrounding tissue, was negligible for gammas and minor for betas. For alpha-emitting particles (e.g., Pu), self-shielding in larger particles is substantial, with >90% of emissions captured within particles of +20 μm diameter; but for smaller sizes of the respirable range of 0.01 to 5 μm, an average of 85% of the energy escapes the particle and is deposited in the surrounding tissues. These data provide more detail on respirable particles, which may remain lodged deep in the lung where they represent a considerable contribution to long-term lung dose rates. For practical dose rate calculation purposes, a graph of particle size vs. dose rates for plutonium-containing hot particles is provided. This study demonstrates one possible approach to dose assessments for biota in environments contaminated by radioactive particles, which may prove useful for those engaged in environmental radioprotection.
Collapse
Affiliation(s)
- Emily Caffrey
- *Oregon State University, School of Nuclear Science and Engineering, 151 Batcheller Hall, Corvallis, OR 97331 (affiliation when work was performed); †Australian Nuclear Science and Technology Organisation, Kirrawee, Australia
| | | | | | | |
Collapse
|
29
|
Sokolnikov M, Preston D, Stram DO. Mortality from solid cancers other than lung, liver, and bone in relation to external dose among plutonium and non-plutonium workers in the Mayak Worker Cohort. Radiat Environ Biophys 2017; 56:121-125. [PMID: 27695960 PMCID: PMC9126197 DOI: 10.1007/s00411-016-0670-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Accepted: 09/17/2016] [Indexed: 05/21/2023]
Abstract
Exposure to ionizing radiation has well-documented long-term effects on cancer rates and other health outcomes in humans. While in vitro experimental studies had demonstrated that the nature of some radiation effects depend on both total dose of the radiation and the dose rate (i.e., the pattern of dose distribution over time), the question of whether or not the carcinogenic effect of radiation exposure depends on the dose rate remains unanswered. Another issue of interest concerns whether or not concomitant exposure to external gamma rays and inhaled plutonium aerosols has any effect on the external exposure effects. The analyses of the present paper focus on the risk of solid cancers at sites other than lung, liver, and bone in Mayak workers. Recent findings are reviewed indicating that there is no evidence of plutonium dose response for these cancers in the Mayak worker cohort. Then the evidence for differences in the external dose effects among workers with and without the potential for exposure to alpha particles from inhaled plutonium is examined. It is found that there is no evidence that exposure to plutonium aerosols significantly affects the risk associated with external exposure. While the Mayak external dose risk estimate of an excess relative risk of 0.16 per Gy is somewhat lower than an appropriately normalized risk estimate from the Life Span Study of Japanese atomic bomb survivors, the uncertainties in these estimates preclude concluding that the external dose excess relative risks of this group of solid cancers differ in the two cohorts.
Collapse
Affiliation(s)
| | - Dale Preston
- Hirosoft International Corporation, Eureka, CA, USA
| | - Daniel O Stram
- Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| |
Collapse
|
30
|
Kirillova EN, Lukyanova TV, Uryadnitskaya TI, Telnov VI. Assessment of the Status of Effector and Regulatory Components of Immune System in Chelyabinsk Region Residents Exposed to Radiation Due to Residence in the Area Contaminated as a Result of the Radiation Accident at Mayak PA and in Their Offspring. Radiats Biol Radioecol 2017; 57:42-52. [PMID: 30698930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Immune status was studied in the framework of the current work and the results of the analysis of concentration of 26 characteristic parameters of innate and acquired immunity in 140 individuals from 56 trios (fathers, mothers and their Ist generation offspring that were included in 2 groups) are presented. Fathers and mothers of the children under study in the main groip Were exposed due to a long-term residence (from childhood to maturity) in the areas of Chelyabinsk region contaminated as a result of the-accident at Mayak PA (contamination included long-lived isotopes - ⁹⁰Sr and, to a smaller extent, ¹³⁷Cs and ²³⁹Pu) and then migrated into Ozyorsk prior to the conception of their children (75 individuals, 33 family trios). Comparison group (control) included parents and their offspring who are Ozyorsk residents never residing in the areas contaminated by radionuclides (65 individuals, 23 family trios). All the investigated individuals from the compared groups were of the corresponding age and gender and had never worked at nuclear facilities. Blood samples were obtained in the periods that excluded oncological, acute infectious and inflammatory diseases of any acute stages of chronic processes. Concentration of immune cells was measured by flow cytometer (Beckman Coulter, USA) using special monoclonal antibodies of the same manufacturer in a licensed medical center "Familia" (Chelyabinsk). The objective of the work is to assess the immune status in parents who migrated from contaminated areas prior to the conception of children and in their 1st generation offspring not exposed to radiation. Alterations of the immune status in the form of increase or, to a smaller extent, decrease of concentration of lymphocytes with effector and/or regulatory functions (B-1, T-helpers, NK, T-NK, late precursors of T-1 and T-1 of late activation) in blood of exposed parents and their offspring were detected in comparison with the results in the control group; that could possibly be related to the stimulation effect of low doses that support activation, proliferation and development of compensatory imbalance in the immune system and immunodeficiency in parents of the main group and in their offspring. In order to reveal the mechanisms of the detected alterations the interrelation between immune damage and incidence, of diseases among the cohorts involved in the current work will be studied further.
Collapse
|
31
|
Malakhova LV, Lomaeva MG, Zakharova ML, Sokolova SN. Deletions in Mitochondrial DNA from the Peripheral Blood of Mayak PA Workers Exposed to Long-Term Ionizing Radiation. Radiats Biol Radioecol 2017; 57:53-59. [PMID: 30698931] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
The number of large deletions of mitochondrial DNA in whole peripheral blood of the former Mayak PA workers occupationally exposed to prolonged γ-radiation has been determined in the long term period after irradiation (mean cumulative dose 135.40 ± 22.03 cGy, age range at the time of blood sampling 67-76 years) and compared with the number of deletions in groups of "young" (19-33 years) and "adult" (66-73 years) individuals who had no contact with radiation sources. Samples of the total DNA from the peripheral blood were obtained from the Radiobiological Human Tissue Repository of the Southern Urals Biophysics Institute (Ozyorsk, Chelyabinsk region) and used for carrying out a long-distance PCR. The analysis of the data showed a statistically significant increase in the number of large deletions in the peripheral blood of "adult" donors of the control group as compared with the control group of "young" donors (51.6 and 14.3%, respec- tively). No statistically significant difference in the number of large deletions in the group of former Mayak PA workers occupationally subjected to prolonged exposure to γ-radiation as compared with the control do- nors of similar age was found (53.6 and 43.8% respectively).
Collapse
|
32
|
Abstract
Plutonium isotopes are of high concern because they lead to high doses. In case of contamination, the activity burden inside the lungs should be assessed accurately. Many studies showed that the presence of breasts has a substantial influence on lung counting efficiencies. Currently, the calibration of most lung counting systems is done by means of physical phantoms representing only male chests. A set of female computational phantoms has been developed in order to provide gender-specific efficiency calibrations for the (241)Am gamma emission (59.54 keV). The phantoms were created starting from a library of female chest phantoms provided by Institut de radioprotection et de sûreté nucléaire (IRSN) (Farah, J. Amélioration des mesures anthroporadiamétriques personnalisées assistées par calcul Monte Carlo: optimisation des temps de calculs et méthodologie de mesure pour l'établissement de la répartition d'activite. PhD Thesis, 2011). While the IRSN phantoms represent a supine measurement position, the SCK•CEN lung counter set-up requires the persons to be sitting in a chair. Using open-source software, the breast shapes of the original phantoms have been recreated to simulate the drooping of breasts in vertical sitting position. A Monte Carlo approach was chosen for calculating calibration coefficients for female lung counting. The results obtained with MCNPx 2.7 simulations showed a significant decrease in the detection efficiency. For bigger bust and breast sizes, the detection efficiency showed to be up to 10 times lower than the ones measured with the Livermore male torso phantom.
Collapse
|
33
|
Leprince B, Fritsch P, Bérard P, Roméo PH. Design and functionalities of the MADOR® software suite for dose-reduction management after DTPA therapy. Radiat Prot Dosimetry 2016; 168:350-357. [PMID: 25999333 DOI: 10.1093/rpd/ncv348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/22/2015] [Accepted: 04/24/2015] [Indexed: 06/04/2023]
Abstract
A software suite on biokinetics of radionuclides and internal dosimetry intended for the occupational health practitioners of nuclear industry and for expert opinions has been developed under Borland C++ Builder™. These computing tools allow physicians to improve the dosimetric follow-up of workers in agreement with the French regulations and to manage new internal contaminations by radionuclides such as Pu and/or Am after diethylene triamine penta-acetic acid treatments. In this paper, the concept and functionalities of the first two computing tools of this MADOR(®) suite are described. The release 0.0 is the forensic application, which allows calculating the derived recording levels for intake by inhalation or ingestion of the main radioisotopes encountered in occupational environment. Indeed, these reference values of activity are convenient to interpret rapidly the bioassay measurements and make decisions as part of medical monitoring. The release 1.0 addresses the effect of DTPA treatments on Pu/Am biokinetics and the dose benefit. The forensic results of the MADOR(®) suite were validated by comparison with reference data.
Collapse
Affiliation(s)
- B Leprince
- CEA/DSV/iRCM 18 route du Panorama, BP 6, F-92265 Fontenay-aux-Roses, France
| | - P Fritsch
- CEA/DSV/iRCM 18 route du Panorama, BP 6, F-92265 Fontenay-aux-Roses, France
| | - P Bérard
- CEA/DSV/PROSITON 18 route du Panorama, BP 6, F-92265 Fontenay-aux-Roses, France
| | - P-H Roméo
- CEA/DSV/iRCM 18 route du Panorama, BP 6, F-92265 Fontenay-aux-Roses, France
| |
Collapse
|
34
|
Liu H, Wakeford R, Riddell A, O'Hagan J, MacGregor D, Agius R, Wilson C, Peace M, de Vocht F. A review of job-exposure matrix methodology for application to workers exposed to radiation from internally deposited plutonium or other radioactive materials. J Radiol Prot 2016; 36:R1-R22. [PMID: 26861451 DOI: 10.1088/0952-4746/36/1/r1] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Any potential health effects of radiation emitted from radionuclides deposited in the bodies of workers exposed to radioactive materials can be directly investigated through epidemiological studies. However, estimates of radionuclide exposure and consequent tissue-specific doses, particularly for early workers for whom monitoring was relatively crude but exposures tended to be highest, can be uncertain, limiting the accuracy of risk estimates. We review the use of job-exposure matrices (JEMs) in peer-reviewed epidemiological and exposure assessment studies of nuclear industry workers exposed to radioactive materials as a method for addressing gaps in exposure data, and discuss methodology and comparability between studies. We identified nine studies of nuclear worker cohorts in France, Russia, the USA and the UK that had incorporated JEMs in their exposure assessments. All these JEMs were study or cohort-specific, and although broadly comparable methodologies were used in their construction, this is insufficient to enable the transfer of any one JEM to another study. Moreover there was often inadequate detail on whether, or how, JEMs were validated. JEMs have become more detailed and more quantitative, and this trend may eventually enable better comparison across, and the pooling of, studies. We conclude that JEMs have been shown to be a valuable exposure assessment methodology for imputation of missing exposure data for nuclear worker cohorts with data not missing at random. The next step forward for direct comparison or pooled analysis of complete cohorts would be the use of transparent and transferable methods.
Collapse
Affiliation(s)
- Hanhua Liu
- Centre for Occupational and Environmental Health, University of Manchester, Manchester, M13 9PL, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
The joint Russian (Mayak Production Association) and British (Sellafield) plutonium worker epidemiological analysis, undertaken as part of the European Union Framework Programme 7 (FP7) SOLO project, aims to investigate potential associations between cancer incidence and occupational exposures to plutonium using estimates of organ/tissue doses. The dose reconstruction protocol derived for the study makes best use of the most recent biokinetic models derived by the International Commission on Radiological Protection (ICRP) including a recent update to the human respiratory tract model (HRTM). This protocol was used to derive the final point estimates of absorbed doses for the study. Although uncertainties on the dose estimates were not included in the final epidemiological analysis, a separate Bayesian analysis has been performed for each of the 11 808 Sellafield plutonium workers included in the study in order to assess: A. The reliability of the point estimates provided to the epidemiologists and B. The magnitude of the uncertainty on dose estimates. This analysis, which accounts for uncertainties in biokinetic model parameters, intakes and measurement uncertainties, is described in the present paper. The results show that there is excellent agreement between the point estimates of dose and posterior mean values of dose. However, it is also evident that there are significant uncertainties associated with these dose estimates: the geometric range of the 97.5%:2.5% posterior values are a factor of 100 for lung dose, 30 for doses to liver and red bone marrow, and 40 for intakes: these uncertainties are not reflected in estimates of risk when point doses are used to assess them. It is also shown that better estimates of certain key HRTM absorption parameters could significantly reduce the uncertainties on lung dose in future studies.
Collapse
Affiliation(s)
- M Puncher
- Centre for Radiation, Chemical and Environmental Hazards, Public Health England, Harwell Oxford, Chilton, OX11 0RQ, UK
| | | |
Collapse
|
36
|
Oradovskaya IV, Radzivil TT. [Influence of Professional Contact with Plutonium-239 on Indicators of the Immune Status of the Personnel at Siberian Chemical Plant]. Radiats Biol Radioecol 2015; 55:565-583. [PMID: 26964342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The results of the examination and monitoring of the personnel at the Siberian Chemical Plant (SChP) and adult population of Seversk are presented. The results of primary examination of the personnel who professionally contact the ionizing radiation (IR) from external sources and incorporated 239Pu showed that clinical symptoms of dysfunction of the immune system manifested themselves with a frequency of 75.30%. Infectious-inflammatory diseases (46.95%) and the combined pathology of infectious and allergic character (20.12%) were the most widespread. The allergic diseases (AD) without manifestations of an infectious component were observed not often (7.62%). The monitoring which was carried out for 10 years revealed a decrease in a percentage of persons with clinical signs of disorders of the immune system up to 60.68% among the personnel at the Chemical-Steel Plant and even more among the whole group of the studied personnel at SChP--49.68% (389 : 783). Among the population their frequency made up 51.78%. Features of clinical manifestations of dysfunction ofthe immune system depending on accumulation of 239Pu in the organism are established. Similar dynamics of infectious and infectious and allergic syndromes is revealed when the activity of 239Pu is 40 nCi. AD frequency reliably increased .when the activity of 239Pu is 20 nCi, but if accumulation is higher than 20-40 nCi it decreases and again increases when the activity is over 40 nCi. Pathologies of infectious and allergic genesis are most often observed when the content of 239Pu in an organism is over 40 nCi. Indicators of the immune status (IS) of the personnel at SChP with incorporated 239Pu are analyzed. 59 people--carriers of 239Pu and 408 people without 239Pu accumulated in an organism are examined. In comparison with the control, IS indicators characteristic for all dose loading groups are revealed: increase of lymphocytes, existence of dissociation in indicators of relative and absolute values of the T-cellular link, CD16+56+(-) NK-cells and B-lymphocytes with increase of absolute values, decrease in markers of activation of HLA-DR+ and CD95+, increase of B-lymphocytes and low level of serum IgM. Features of IS in comparison with the group of the personnel with the absence of 239Pu in an organism and indicators of IS which depend on the activity of 239Pu are established. Among them are a decrease in the percentage of persons with increased number of lymphocytes with increased beam loading; increase of NK-T-cells when the activity of 239Pu is 10-20 nCi and the highest value at doses over40 nCi; the dynamics of CD16+56(+)-lymphocytes with the increase of the contents and a percentage of persons with the increase of the activity above 40 nCi; the highest frequenc of a regulatory imbalance with high frequency decrease of CD8(+)-T-lymphocytes at the content of 239Pu > 0-10 nCi; decrease in indicators of B-lymphocytes and serum IgA with an increase in the activity of 239Pu with the lowest values under internal radiation over 40 nCi; decrease in the percentage of persons with a weakening expression of HLA-DR+ with the increase in dose loading.
Collapse
|
37
|
Curwen GB, Sotnik NV, Cadwell KK, Azizova TV, Hill MA, Tawn EJ. Chromosome aberrations in workers with exposure to α-particle radiation from internal deposits of plutonium: expectations from in vitro studies and comparisons with workers with predominantly external γ-radiation exposure. Radiat Environ Biophys 2015; 54:195-206. [PMID: 25649482 DOI: 10.1007/s00411-015-0585-6] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2014] [Accepted: 01/12/2015] [Indexed: 06/04/2023]
Abstract
mFISH analysis of chromosome aberration profiles of 47 and 144 h lymphocyte cultures following exposure to 193 mGy α-particle radiation confirmed that the frequency of stable aberrant cells and stable cells carrying translocations remains constant through repeated cell divisions. Age-specific rates and in vitro dose-response curves were used to derive expected translocation yields in nine workers from the Mayak nuclear facility in Russia. Five had external exposure to γ-radiation, two of whom also had exposure to neutrons, and four had external exposure to γ-radiation and internal exposure to α-particle radiation from incorporated plutonium. Doubts over the appropriateness of the dose response used to estimate translocations from the neutron component made interpretation difficult in two of the workers with external exposure, but the other three had translocation yields broadly in line with expectations. Three of the four plutonium workers had translocation yields in line with expectations, thus supporting the application of the recently derived in vitro α-particle dose response for translocations in stable cells. Overall this report demonstrates that with adequate reference in vitro dose-response curves, translocation yield has the potential to be a useful tool in the validation of red bone marrow doses resulting from mixed exposure to external and internal radiation.
Collapse
Affiliation(s)
- Gillian B Curwen
- Centre for Integrated Genomic Medical Research (CIGMR), School of Population Health, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, M13 9PT, UK
| | | | | | | | | | | |
Collapse
|
38
|
Tel'nov VI. [PLUTONIUM AND LIFETIME REDUCTION AMONG PROFESSIONAL WORKERS FSUE]. Gig Sanit 2015; 94:56-60. [PMID: 26302561] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
The objective of the study is the assessment of lifetime in the cohort of Mayak PA workers employed in 1948-1958 and exposed to incorporated Pu-239. The decrease of age at death 5.2 years among males and 6.6 years among females, and after the start of work--6.9 years among males and 7.7 years among females, with the increase of Pu-239 incorporation was shown. The association of the raised mortality rate from tumour causes is shown both among males and females, mainly due to malignant neoplasms of lung and live; which are organs of Pu-239 main deposition. For the first time related to Pu-239 incorporation decrease of age at death from tumour and non-tumour causes of main and secondary organs of deposition both among males and females was revealed. To assess the reduction of lifetime Years of Potential Life Lost (YPLL) were calculated per 10(5) person-years of potential life based on European gender standard. The calculations based on the obtained estimations showed significant dependence of YPLL on the level of Pu-239 incorporation. At that the main contribution to the increase of YPLL, i.e. to lifetime reduction, was due to radiation-induced decrease of the age at death as compared to radiation-induced increase of mortality rates.
Collapse
|
39
|
Simmons JA. Microdosimetric considerations of lung cancer risks from plutonium. Health Phys 2015; 108:377-379. [PMID: 25627951 DOI: 10.1097/hp.0000000000000181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
New data from the workers at the Mayak nuclear facility near Chelyabinsk, Russia, apparently show a linear increase in the risk of lung cancer with increasing dose. Furthermore, this increase occurs without a threshold. However, these conclusions are at variance with the results reported by other investigators. A possible cause of these inconsistencies could be the lack of application of microdosimetric considerations when discussing "dose" to the lung.
Collapse
|
40
|
Nicolaou G. Radiation dose aspects in the handling of emerging nuclear fuels. Radiat Prot Dosimetry 2014; 162:459-462. [PMID: 24553050 DOI: 10.1093/rpd/ncu016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
The occupational annual dose levels, encountered at fabrication of emerging nuclear fuels, have been studied. Emerging fuels for the single and multiple recycling of Pu and MA have resulted in considerably higher gamma and neutron doses in comparison with commercial fuels. The occupational dose limit is exceeded at fabrication by a single fuel rod in all fuel cases with (241)Am and Cm isotopes present in their composition. In the absence of these isotopes, 2-4 adjacent fuel rods are sufficient to exceed the limit. Self-shielding within the fuel reduces significantly only the gamma dose that would have been delivered otherwise. Hence, only the first row of fuel rods in an assembly contributes to the dose, whereas in the case of neutrons, all fuel rods contribute.
Collapse
Affiliation(s)
- G Nicolaou
- Laboratory of Nuclear Technology, Department of Electrical and Computer Engineering, School of Engineering, Demokritus University of Thrace, Xanthi 67100, Greece
| |
Collapse
|
41
|
Sokolova AB, Suslova KG, Efimov AV, Miller SC. Use of in vivo counting measurements to estimate internal doses from (241)Am in workers from the Mayak production association. Health Phys 2014; 107:135-142. [PMID: 24978284 DOI: 10.1097/hp.0000000000000081] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Comparisons between results of in vivo counting measurements of americium burden and results from radiochemical analyses of organ samples taken at autopsy of 11 cases of former Mayak workers were made. The in vivo counting measurements were performed 3-8 y before death. The best agreement between in vivo counting measurements for americium and autopsy data was observed for the skull. For lungs and liver, the ratios of burden measured by in vivo counting to those obtained from radiochemical analyses data ranged from 0.7-3.8, while those for the skull were from 1.0-1.1. There was a good correlation between the estimates of americium burden in the entire skeleton obtained from in vivo counting with those obtained from autopsy data. Specifically, the skeletal burden ratio, in vivo counting/autopsy, averaged 0.9 ± 0.1. The prior human americium model, D-Am2010, used in vivo counting measurements for americium in the skeleton to estimate the contents of americium and plutonium at death. The results using this model indicate that in vivo counting measurements of the skull can be used to estimate internal doses from americium in the Mayak workers. Additionally, these measurements may also be used to provide a qualitative assessment of internal doses from plutonium.
Collapse
Affiliation(s)
- Alexandra B Sokolova
- *Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk Region, Russia; †Radiobiology Division, School of Medicine, University of Utah, Salt Lake City, UT
| | | | | | | |
Collapse
|
42
|
Simonetto C, Azizova TV, Grigoryeva ES, Kaiser JC, Schöllnberger H, Eidemüller M. Ischemic heart disease in workers at Mayak PA: latency of incidence risk after radiation exposure. PLoS One 2014; 9:e96309. [PMID: 24828606 PMCID: PMC4020749 DOI: 10.1371/journal.pone.0096309] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2013] [Accepted: 04/06/2014] [Indexed: 12/31/2022] Open
Abstract
We present an updated analysis of incidence and mortality from atherosclerotic induced ischemic heart diseases in the cohort of workers at the Mayak Production Association (PA). This cohort constitutes one of the most important sources for the assessment of radiation risk. It is exceptional because it comprises information on several other risk factors. While most of the workers have been exposed to external gamma radiation, a large proportion has additionally been exposed to internal radiation from inhaled plutonium. Compared to a previous study by Azizova et al. 2012, the updated dosimetry system MWDS-2008 has been applied and methods of analysis have been revised. We extend the analysis of the significant incidence risk and observe that main detrimental effects of external radiation exposure occur after more than about 30 years. For mortality, significant risk was found in males with an excess relative risk per dose of 0.09 (95% CI: 0.02; 0.16) [Formula: see text] while risk was insignificant for females. With respect to internal radiation exposure no association to risk could be established.
Collapse
Affiliation(s)
- Cristoforo Simonetto
- Helmholtz Zentrum München, Department of Radiation Sciences, Neuherberg, Germany
- * E-mail:
| | - Tamara V. Azizova
- Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk Region, Russia
| | | | - Jan C. Kaiser
- Helmholtz Zentrum München, Department of Radiation Sciences, Neuherberg, Germany
| | - Helmut Schöllnberger
- Helmholtz Zentrum München, Department of Radiation Sciences, Neuherberg, Germany
| | - Markus Eidemüller
- Helmholtz Zentrum München, Department of Radiation Sciences, Neuherberg, Germany
| |
Collapse
|
43
|
Labutina EV, Kuznetsova IS, Hunter N, Harrison J, Koshurnikova NA. Radiation risk of malignant neoplasms in organs of main deposition for plutonium in the cohort of Mayak workers with regard to histological types. Health Phys 2013; 105:165-176. [PMID: 23799501 DOI: 10.1097/hp.0b013e31828f57df] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
This paper presents the results of analyses of the incidence of malignant neoplasms in lung, liver, and bone and associated connective tissues among Mayak nuclear workers exposed to both internally incorporated plutonium and to external gamma radiation. The study cohort included 22,373 individuals employed at the reactors and radiochemical and plutonium production facilities of the Mayak nuclear complex during 1948-1982 and followed up to the end of 2004. All analyses were carried out by Poisson regression, and the doses used were derived using a recently available update of organ doses, Mayak doses-2008. There was clear evidence for the linear association between internal plutonium dose and the risk of lung cancer. For males, there was evidence of a significant internal plutonium dose response for all histological types of lung cancer evaluated (adenocarcinoma, squamous-cell, and other epithelial); the estimated excess relative risk (ERR)/Gy for adenocarcinoma was the largest (ERR/Gy = 32.5; 95% CI: 16.3; 71.9), about 11-fold higher than that for squamous-cell lung cancer (ERR/Gy = 3.1; 95% CI: 0.3; 9.1). The relationship between liver cancer risk and plutonium exposure was best described by a linear-quadratic (LQ) function, but the LQ effect was diminished after restricting internal doses <2 Gy. Hepatocellular cancer was the most frequently observed type of liver cancer associated with internal plutonium exposure, and hemangiosarcomas were exclusively observed only at high internal plutonium doses (>4 Gy). For malignant neoplasms of bone and associated connective tissues, the trend was not statistically significant in relation to internal plutonium dose, but a statistically significantly higher risk (RR=13.7; 95% CI= 3.0; 58.5) was found among unmonitored female plutonium workers who were employed in the most hazardous plutonium production facility commissioned prior to 1950.
Collapse
Affiliation(s)
- E V Labutina
- Southern Urals Biophysics Institute (SUBI), Ozyorsk, Chelyabinsk Region, Russia.
| | | | | | | | | |
Collapse
|
44
|
Abstract
Skin penetration by radionuclide contaminants serves as a route of entry into the body and may pose a serious health risk to humans depending on the magnitude of intake. The United States Transuranium and Uranium Registry whole body Case 0262 was involved in a wound intake of plutonium at the Hanford Site. The registrant died about 33 years later. Results were initially reported in 2007 regarding the deposition and retention of plutonium in various tissues, including the wound site. However in 2009, an additional (previously unrecorded) sample of the wound tissue was located in the National Human Radiobiological Tissue Repository. The new sample was analyzed using inductively coupled plasma-mass spectrometry (ICP-MS), and the results were used to calibrate the measurement of emitted Pu x-rays from the original wound tissue sample made in 2007. In the present study, the analysis of Pu absorption rates from the wound and axillary lymph node from the initial study is repeated using the additional wound activity data and ICP-MS calibration. This new analysis is carried out using the Weighted Likelihood Monte Carlo Sampling (WeLMoS) method and code, which applies Bayesian inference to calculate the posterior probability distribution of intake and wound absorption parameters directly from the observed data and the assumed biokinetic model structure. The resulting central estimates of empirical wound absorption parameters and their associated uncertainties are here compared with the empirical values recommended in NCRP Report No. 156 for plutonium and with the maximum likelihood point estimates derived in the initial study from the Case 0262 data available at the time.
Collapse
Affiliation(s)
- Shane N Weber
- Idaho State University, Department of Nuclear Engineering and Health Physics, Pocatello, ID 83209, USA
| | | | | |
Collapse
|
45
|
Avtandilashvili M, Brey R, James AC. Maximum likelihood analysis of bioassay data from long-term follow-up of two refractory PuO2 inhalation cases. Health Phys 2012; 103:70-79. [PMID: 22647919 DOI: 10.1097/hp.0b013e31824ac627] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The U.S. Transuranium and Uranium Registries' tissue donors 0202 and 0407 are the two most highly exposed of the 18 registrants who were involved in the 1965 plutonium fire accident at a defense nuclear facility. Material released during the fire was well characterized as "high fired" refractory plutonium dioxide with 0.32-μm mass median diameter. The extensive bioassay data from long-term follow-up of these two cases were used to evaluate the applicability of the Human Respiratory Tract Model presented by International Commission on Radiological Protection in Publication 66 and its revision proposed by Gregoratto et al. in order to account for the observed long-term retention of insoluble material in the lungs. The maximum likelihood method was used to calculate the point estimates of intake and tissue doses and to examine the effect of different lung clearance, blood absorption, and systemic models on the goodness-of-fit and estimated dose values. With appropriate adjustments, Gregoratto et al. particle transport model coupled with the customized blood absorption parameters yielded a credible fit to the bioassay data for both cases and predicted the Case 0202 liver and skeletal activities measured postmortem. PuO2 particles produced by the plutonium fire are extremely insoluble. About 1% of this material is absorbed from the respiratory tract relatively rapidly, at a rate of about 1 to 2 d (half-time about 8 to 16 h). The remainder (99%) is absorbed extremely slowly, at a rate of about 5 × 10(-6) d (half-time about 400 y). When considering this situation, it appears that doses to other body organs are negligible in comparison to those to tissues of the respiratory tract. About 96% of the total committed weighted dose equivalent is contributed by the lungs. Doses absorbed by these workers' lungs were high: 3.2 Gy to AI and 6.5 Gy to LNTH for Case 0202 (18 y post-intake) and 3.2 Gy to AI and 55.5 Gy to LNTH for Case 0407 (43 y post-intake). This evaluation supports the Gregoratto et al. proposed revision to the ICRP 66 model when considering situations of extremely insoluble particles.
Collapse
Affiliation(s)
- Maia Avtandilashvili
- Department of Nuclear Engineering and Health Physics, Idaho State University, Pocatello, ID 83209-8060, USA.
| | | | | |
Collapse
|
46
|
Fallahian NA, Brey RR, Tivis RD, Piland NF, Simpson DR. Cancer deaths and occupational exposure in a group of plutonium workers. Health Phys 2012; 102:443-452. [PMID: 22378206 DOI: 10.1097/hp.0b013e31823dc308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
An exploratory epidemiological study was conducted for 319 deceased nuclear workers who had intakes of transuranic radionuclides and histories of employment during the time period from 1943 to 1995. The workers were employed at various facilities throughout the United States, including the Department of Energy defense facilities and uranium mining and milling sites. The majority of individuals were involved in documented radiological incidents during their careers. All had voluntarily agreed to donate their organs or whole body to the United States Transuranium and Uranium Registries. External and internal dose assessments were performed using occupational exposure histories and postmortem concentrations of transuranic radionuclides in critical organs. Statistical data analyses were performed to investigate the potential relationship between radiation exposure and causes of death within this population due to cancers of the lungs, liver, and all sites combined while controlling for the effects of other confounders. No association was found between radiation exposure and death due to cancer (α = 0.05). However, statistically significant associations were found between death due to any type of cancer and smoking (yes or no) (odds ratio = 5.41; 95% CI: 1.42 to 20.67) and rate of cigarette smoking (packs per day) (odds ratio = 2.70; 95% CI: 1.37 to 5.30).
Collapse
Affiliation(s)
- Naz Afarin Fallahian
- Bloomsburg University, Department of Physics and Engineering Technology, 400 East 2nd Street, Bloomsburg, PA 17815-1301, USA.
| | | | | | | | | |
Collapse
|
47
|
Barabanova T, Wiley AL, Bushmanov A. Dose-dependent analysis of acute medical effects of mixed neutron-gamma radiation from selected severe 235U or 239Pu criticality accidents in USSR, United States, and Argentina. Health Phys 2012; 102:391-399. [PMID: 22378200 DOI: 10.1097/hp.0b013e31823b4b78] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Eight of the most severe cases of acute radiation disease (ARS) known to have occurred in humans (as the result of criticality accidents) had survival times less than 120 h (herein defined as "early death"). These accidents were analyzed and are discussed with respect to the specific accident scenarios and the resulting accident-specific, mixed neutron-gamma radiation clinical dose distributions. This analysis concludes that the cardiovascular system appears to be the most critical organ system failure for causing "early death" following approximate total body, mixed gamma-neutron radiation doses greater than 40-50 Gy. The clinical data also suggest that there was definite chest dose dependence in the resulting survival times for these eight workers, who unfortunately suffered profound radiation injury and unusual clinical effects from such high dose radiation exposures. In addition, "toxemic syndrome" is correlated with the irradiation of large volumes of soft tissues. Doses to the hands or legs greater than 80-100 Gy or radiation lung injury also play significant but secondary roles in causing "early death" in accidents delivering chest doses greater than 50 Gy.
Collapse
Affiliation(s)
- Tatyana Barabanova
- Burnasyan Federal Medical Biophysical Center of the Federal Medical Biological Agency, Moscow, Russia
| | | | | |
Collapse
|
48
|
Azizova TV, Moseeva MB, Grigor'eva ES, Muirhed CR, Hunter N, Haylock RGE, O'Hagan JA. [Mortality risk of cardiovascular diseases for occupationally exposed workers]. Radiats Biol Radioecol 2012; 52:158-166. [PMID: 22690578] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Results of the risk analysis of mortality from ischemic heart disease (IHD) in the cohort of Mayak nuclear workers (18763 individuals) first employed in 1948-1972, with follow-up to 31.12.2005, were summarized. The mortality risk of IHD in the cohort of Mayak workers depended on the non-radiation factors such as gender, age, calendar period, smoking, alcohol consumption, arterial hypertension, body mass index. There was no statistically significant relationship between mortality from 1HD and total external dose. The risk of mortality from IHD was significantly higher for workers exposed to the total absorbed dose to liver > 0.025 Gy from internal alpha-radiation. There was a significantly increasing trend (ERR/Gy) of the IHD mortality with the total absorbed dose to liver from internal alpha-radiation due to incorporated plutonium. However, there was a decreasing trend of ERR/Gy with restriction of the follow-up to Ozyorsk and adjustment for the external dose.
Collapse
|
49
|
Moseeva MB, Azizova TV, Muirhed CR, Grigor'eva ES, Vlasenko EV, Sumina MV, O'Hagan JA, Zang W, Haylock RGE, Hunter N. [Risk of cerebrovascular disease incidence in the cohort of Mayak production association workers first employed during 1948-1958]. Radiats Biol Radioecol 2012; 52:149-157. [PMID: 22690577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Incidence of cerebrovascular diseases (CVD) has been studied in a cohort of 12210 workers first employed at one of the main plants (reactors, radiochemical or plutonium) of the Mayak nuclear facility during 1948-1958 and followed up to the end of 2000. Information on external gamma doses is available for virtually all (99.9%) of these workers; the mean (+/- one standard deviation) total gamma dose was 0.91 +/- 0.95 Gy (99% percentile 3.9 Gy) for men and 0.65 +/- 0.75 Gy (99% percentile 2.99 Gy) for women. Plutonium body burden was measured only for 30.0% of workers. Amongst those monitored, the mean (+/- standard deviation) cumulative liver dose from plutonium alpha exposure was 0.40 +/- 1.15 Gy (99% percentile 5.88 Gy) for men and 0.81 +/- 4.60 Gy (99% percentile 15.95 Gy) for women 4418 cases (first diagnosis) of CVD were identified in the studied cohort. A statistically significant increasing trend in CVD incidence with total external gamma dose was revealed after adjustment for non-radiation factors and internal exposure from incorporated plutonium-239. Excess relative risk per Gy was 0.464 (95% confidence interval 0.360-0.567). Incidence of CVD was statistically significantly higher for the workers chronically exposed to external gamma rays at a dose above 1.0 Gy A statistically significant increasing trend in CVD incidence with internal liver dose from plutonium alpha exposure was observed after adjustment for non-radiation factors and external exposure. ERR per Gy was 0.155 (95% confidence interval 0.075-0.235). CVD incidence was statistically significantly higher among workers with a plutonium liver dose above 0.1 Gy, although the trend estimates differed between workers at different plants. The incidence risk estimates for external radiation are generally compatible with estimates from the study of Chernobyl clean-up workers, although the incidence data point to higher risk estimates compared to those from the Japanese A-bomb survivors.
Collapse
|
50
|
Chunikhin LA, Drozdov DN. [The assessment of accumulated internal irradiation doses of the inhabitants of the populated areas in Republik Belarus after Chernobyl accident]. Radiats Biol Radioecol 2012; 52:167-174. [PMID: 22690579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
A new system of evaluation methods has been developed for the assessment of the accumulated internal irradiation doses in the inhabitants of the populated areas of the Republic of Belarus that were contaminated by the Chernobyl radionuclides. The system is based on the results of WBC measurements. The model is based on the WBC-results of the State Dosimetric Register for the period of 1987-2010. The dose assessment model is based on the classification of the populated areas, on the regional features of the soils through which 137Cs can enter into the locally grown and produced foods. The model is also based on building the regressive correlations of accumulated internal doses to the contamination density of the territory of a populated area. Such regressive correlations are made for each region. The influence of indirect factors of dose forming was taken into consideration in the dose assessment. Among these factors are the population of the area, and the amount of forested territory around it, which were taken as correction coefficients. The coefficients were determined from the regressive correlation of the correction coefficients to a specific area of forest for each region. So called "countermeasure factor" was used for specification of other model results.
Collapse
|